Börskollen - Aktier, fonder och ekonominyheter
Börskollen
Sparvalet: Så kan du gå miste om upp till 34 000 kronor på tre år - gör detta istället

Analyser av BICO Group

Kurs från TradingView
Visa mer ▼
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts

BICO (Q2 review): A directionally positive report - Redeye

BICO's Q2 marked a second consecutive quarter of positive organic growth, alongside a return to EBITDA profitability as cost savings began t...

Redeye • 20 aug 11:47

BICO (Q2 Initial take): A return to organic growth and EBITDA profitability - Redeye

BICO's Q2 report slightly missed on sales as project-based softness persisted, but a sharp margin recovery, and positive EBITDA offers an ea...

Redeye • 19 aug 10:05

BICO (Q1 review): Organic growth at no-growth multiples - Redeye

BICO delivered 11% organic growth in Q1 2026, although coming in slighty behind our estimates in absolute terms.

Redeye • 04 maj 08:07

BICO (Q1 initial take): Organic growth and restructuring costs - Redeye

The Q1 report came in slightly below our projections showing organic growth of 11% in local currencies, an encouraging signal, however FX he...

Redeye • 29 apr 10:59

BICO (Q4 review): Improving outlook and trades at <1x sales - Redeye

BICO’s Q4 report broadly aligned with our estimates, showing slightly negative organic growth and adjusted EBITDA profitability of 12.

Redeye • 20 feb 08:22

BICO (Q4 initial take): Report in line with our estimates - Redeye

BICO's Q4 report aligned closely with our projections and does not prompt any meaningful change to our view of the case.

Redeye • 18 feb 09:46

BICO (Q4 preview): Recalibration ahead of the report - Redeye

Redeye provides a preview of its estimates ahead of BICO’s Q4 results, scheduled for release on November 4.

Redeye • 16 feb 14:58

BICO (Q3 Review): A return to organic growth and adjusted EBITDA profitability - Redeye

Redeye updates its estimates and fair value range following BICO’s Q3 2025 report showing a return to organic growth in line with our projec...

Redeye • 14 nov 2025 08:11

BICO (Q3 initial take): Solid report but another major impairment - Redeye

Redeye provides its initial comments on BICO following its Q3 results, which came in above expectations overall.

Redeye • 04 nov 2025 11:55

BICO (Q3 Preview): Polished estimates - Redeye

Redeye provides a preview of its estimates ahead of BICO’s Q3 results, scheduled for release on November 4.

Redeye • 22 okt 2025 12:38

BICO Group: A Forgotten Darling with Turnaround Potential - Redeye

Redeye initiates coverage of BICO, a leading player in the bioconvergence space.

Redeye • 28 aug 2025 07:24